Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check6 days agoChange DetectedA new publication citation for Tolebrutinib liver safety was added and the page revision updated to v3.6.5. The plain language results summary, sponsor label, and Helpful Links section were removed as part of a UI/content cleanup.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision label Revision: v3.6.4 appears on the page, replacing the previous v3.6.3. This indicates a minor update to the page's version without altering the study details.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a newly released iteration of the page's content. This update appears to be a technical revision rather than a change in user-facing information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This reflects a minor update or maintenance release of the page rather than a change to study details or content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now signals that recruitment is closed to new participants and adds How to Read a Study Record, Common Questions, and How to Join a Study for user guidance. The Interventions header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision indicator was updated to Revision: v3.6.0.SummaryDifference0.2%

- Check71 days agoChange DetectedA new revision tag 'Revision: v3.5.5' has been added, and the previous 'Revision: v3.5.4' has been removed. This signals a refreshed release of the page content.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.